CASP9 and ovarian carcinoma: In women with ovarian cancer, the mean caspase-9 concentration was 4.02 ± 1.88 ng/mL ranging from 1.40 ng/mL to 8.30 ng/mL and was significantly reduced compared to the control group (p ˂ 0.001).